GLP-1 · Bilingual Telehealth · NY
New York is home to one of the largest and most diverse Latino communities in the world — over 2.5 million Hispanic residents: Dominican, Puerto Rican, Mexican, Colombian, Ecuadorian, and more. REMEVi offers truly bilingual telehealth with New York-licensed physicians for GLP-1 treatments.
Free · about 1 minute · no card required
New York has the world's most diverse Latino community. REMEVi speaks all its languages.
New York · New York County
From Washington Heights to Sunset Park, from Jackson Heights to the South Bronx, New York's Latino community is the most diverse in the world. This diversity also brings unique challenges: Spanish variations between Dominican, Caribbean, and South American communities can make generic translations fail to communicate medical information accurately. REMEVi employs bilingual clinical staff whose Spanish is adapted for US Hispanic communities, with New York-licensed physicians who review each case and provide clear dosing instructions in the right cultural context.
New York's Hispanic and Latino community — over 2,500,000+ residents — spans Mexican, Cuban, Puerto Rican, Central American, and South American roots, each with its own food traditions, family dynamics, and relationship with the US healthcare system. What's consistent across all of them: being understood without a translator, without cultural assumptions, and without having to explain why arroz con frijoles isn't a "problem to eliminate" but a reality to integrate into a sustainable weight loss plan.
Across New York County, roughly 24.8% of adults live with obesity. For Latinas, the numbers are steeper — elevated rates of type 2 diabetes, metabolic syndrome, and insulin resistance combine with cultural and linguistic barriers that slow access to endocrinology and obesity specialists. GLP-1 medications (semaglutide and tirzepatide) are among the most studied and effective tools we have today, but they only work when the patient can speak to their licensed provider in their own language.
One flat price at every dose. Most weight-loss programs raise your price every time your dose goes up — REMEVi never does. Visit, medication, coaching and shipping — one number. No separate membership fee. (Many programs add a $79–$149/mo membership on top of the medication price.)
Provider-managed weekly injection. The same compounded GLP-1 as the big-brand competitors — with bilingual care, no insurance, no dose upcharges.
Daily oral semaglutide. Same clinical oversight, same bilingual care — without the needle.
Dual-agonist tirzepatide. The strongest average loss in the GLP-1 category — provider-managed, bilingual care.
¹ Clinical-trial results for semaglutide (STEP-1, NEJM 2021) and tirzepatide (SURMOUNT-1, NEJM 2022) — the active medications in REMEVi protocols, not REMEVi outcomes or guarantees. Compounded preparations are not FDA-approved and have not been studied as finished products. Individual results vary.
How It Works · Cómo Funciona
From intake to medication in days, not weeks. Bilingual throughout.
100% private, from your phone. English or Spanish. If you qualify, a 5-minute medical intake follows.
A New York-licensed clinician reviews your history and confirms candidacy.
Free overnight cold-chain shipping, discreetly packaged, to your New York address.
Dose adjustments, coaching, and ongoing support — bilingual throughout.
The Care Team
The licensed providers treating patients through REMEVi are actively licensed in New York, board-certified, with experience across endocrinology, internal medicine, and obesity medicine. Every provider holds an NPI (National Provider Identifier) verifiable in the federal registry.
On safety and privacy: REMEVi is 100% HIPAA-compliant. Your medical information is never sold, never shared with insurance companies, and never used for advertising. Our compounding pharmacies are state-licensed and our clinical operations follow FDA and state medical board guidelines.
FAQ
Clear answers on GLP-1, telemedicine, and how REMEVi works in New York.
Yes. Telemedicine is fully legal in New York. All licensed providers working with REMEVi hold active New York medical licenses and comply with state telemedicine regulations, federal HIPAA law, and FDA prescribing guidelines.
After your provider approves your plan (typically within 24 hours of intake), your medication ships within 48 hours from a state-licensed compounding pharmacy with free overnight cold-chain shipping to your New York address. All shipments are discreet — no labels identifying the contents.
REMEVi's compounded semaglutide and compounded tirzepatide are not the same as, and are not generic versions of, Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. Those branded products are FDA-approved finished drugs manufactured by Novo Nordisk and Eli Lilly. REMEVi's compounded preparations are non-FDA-approved and are prepared by state-licensed US compounding pharmacies under individual prescriptions from licensed US providers. Compounded preparations have not been clinically studied as finished products. Your licensed provider will review the risks, benefits, and considerations with you before prescribing.
No. REMEVi is a direct-pay service with 100% transparent pricing — we don't accept insurance and don't file claims. The price you see is the price you pay. This also means your medical information is never shared with insurance companies.
Yes. REMEVi was built bilingual from day one. Spanish isn't auto-translation — it's our native voice. Your intake, your provider, your educational materials, and your ongoing support are all available in Spanish with no delays, no third-party translators, and no compromise in care quality.
REMEVi serves all of New York, not just New York. If you live anywhere in New York and we have a licensed provider there (we do), we can treat you. Shipping reaches residential addresses and PO boxes alike.
Yes. The monthly plan has no contract — pause or cancel anytime from your patient dashboard with no penalties. The prepaid 12-week and 52-week plans simply don't renew at the end of their term; see our Cancellation & Refund Policy for early-cancellation details.
GLP-1s (semaglutide and tirzepatide) have been extensively studied for over a decade and are FDA-approved for type 2 diabetes and weight loss. Most common side effects are mild nausea, stomach upset, and constipation during the first few weeks. Your bilingual provider titrates the dose gradually to minimize these effects. Before prescribing, we review your full medical history to rule out contraindications.
Locations · Ubicaciones
REMEVi serves patients in New York and across the US. Same bilingual care: semaglutide $149 first month, tirzepatide $249 first month — or as low as $199/mo and $269/mo on 52-week plans, all-inclusive.
Take the free 1-minute quiz. A New York-licensed bilingual clinician reviews your case within 24 hours.
See if you qualifyFree · about 1 minute · no card required
What GLP-1 is, how it works, what to expect, and nutrition tips — in English and Spanish. Free, straight to your inbox.
No spam. Unsubscribe anytime.
Free · no card required
